PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,881,034 | -4.3% | 339,160 | 0.0% | 100.00% | +196.7% |
| Q2 2023 | $6,145,579 | -87.4% | 339,160 | -81.6% | 33.70% | -42.8% |
| Q1 2023 | $48,921,656 | +37.6% | 1,839,160 | 0.0% | 58.97% | +111.7% |
| Q4 2022 | $35,550,963 | -55.7% | 1,839,160 | -52.1% | 27.86% | -20.4% |
| Q3 2022 | $80,200,000 | +71.5% | 3,839,160 | -34.3% | 35.02% | +83.1% |
| Q2 2022 | $46,772,000 | +14.3% | 5,839,160 | 0.0% | 19.13% | +72.2% |
| Q1 2022 | $40,933,000 | -48.1% | 5,839,160 | 0.0% | 11.11% | -43.7% |
| Q4 2021 | $78,829,000 | -20.0% | 5,839,160 | 0.0% | 19.73% | +5.4% |
| Q3 2021 | $98,565,000 | -42.0% | 5,839,160 | 0.0% | 18.71% | -37.0% |
| Q2 2021 | $170,036,000 | -26.0% | 5,839,160 | 0.0% | 29.69% | +2.2% |
| Q1 2021 | $229,654,000 | +73.1% | 5,839,160 | 0.0% | 29.05% | +154.9% |
| Q4 2020 | $132,666,000 | +0.3% | 5,839,160 | 0.0% | 11.39% | +2.6% |
| Q3 2020 | $132,257,000 | -30.2% | 5,839,160 | 0.0% | 11.11% | -59.8% |
| Q2 2020 | $189,539,000 | – | 5,839,160 | – | 27.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |